MindChild Medical
Private Company
Funding information not available
Overview
MindChild Medical, founded in 2009 and headquartered in North Andover, Massachusetts, is a private medical device company commercializing its innovative MERIDIAN M110 system. The technology addresses critical gaps in labor and delivery monitoring by providing gold-standard signal quality non-invasively, eliminating risks associated with scalp electrodes and intrauterine catheters while solving signal degradation in patients with high BMI. Its solution promises to improve obstetric safety, reduce nursing workload, and set a new standard in continuous fetal monitoring. The company is in the commercial stage with an FDA-cleared product, positioning it to capture share in the large and established fetal monitoring market.
Technology Platform
Proprietary non-invasive electrophysiological monitoring platform using abdominal surface electrodes and advanced signal processing algorithms to separate and analyze fetal ECG, maternal ECG, and uterine EMG signals for continuous intrapartum monitoring.
Opportunities
Risk Factors
Competitive Landscape
MindChild competes against major medical device companies like GE HealthCare, Philips, and Baxter (Hill-Rom) that dominate the fetal monitoring market with traditional Doppler/TOCO systems. Its key differentiation is providing non-invasive, ECG-quality data that eliminates the need for invasive scalp electrodes and pressure catheters, a claim not matched by the standard offerings of these incumbents.